Drawing for LUMALIFE

USPTO serial 99522922

LUMALIFE

Status 641Office Action
Filing date
Dec 1, 2025
Status date
Apr 3, 2026
Registration date
Examiner
DONEGAN, DANIEL P

Need help with LUMALIFE?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: July 3rd, 2026

Office Action issues

The USPTO found no conflicting trademarks, but they have rejected the evidence of how you use your mark for all goods and services because it does not show a clear way for customers to purchase your products or a direct link to your services.

Owner

  • Gerard Marius Xavier Fernando

    San Jose, CA, US

Goods and services

ClassDescriptionStatusFirst use
009Software as a Medical Device (SaMD), recorded, for use as a medical instrument for diagnosis of medical conditions; Recorded Software as a Medical Device (SaMD) for use as a medical instrument for scanning human organs; Downloadable Software as a Medical Device (SaMD) for diagnosing and treating liver disease; Downloadable Software as a Medical Device (SaMD) for diagnosing and treating kidney diseaseACTIVENov 1, 2025
010Medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tractACTIVENov 1, 2025
042Software as a service (SAAS) services featuring software for medical diagnosisACTIVENov 1, 2025
044Medical testing services relating to the diagnosis and treatment of disease; Medical diagnostic services; Medical diagnostic testing, monitoring and reporting services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratoriesACTIVENov 1, 2025

Prosecution history

DateCodeEvent
Jun 2, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 2, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 3, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2026GNRTNON-FINAL ACTION E-MAILED
Apr 3, 2026CNRTNON-FINAL ACTION WRITTEN
Apr 2, 2026DOCKASSIGNED TO EXAMINER
Feb 12, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Dec 1, 2025NWAPNEW APPLICATION ENTERED

Related guidance